Generic Pharmaceutical Firms
-
{
- All
- News
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
- Saturday March 21, 2026
- Feature | Edited by Nikhil Pandey
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
www.ndtv.com
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
- Saturday March 21, 2026
- Health | Indo-Asian News Service
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
www.ndtv.com
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
- Friday September 26, 2025
- World News | Edited by Sanstuti Nath
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
www.ndtv.com
-
Zydus Cadila's US Firm Gets US Approval To Market Roflumilast Tablets
- Monday February 14, 2022
- World News | Press Trust of India
Cadlia Healthcare Ltd on Monday said group firm Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market its generic version of Roflumilast tablets in the strength of 500 mcg indicated to reduce the risk of
-
www.ndtv.com
-
High Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of Novartis
- Tuesday November 2, 2021
- India News | Press Trust of India
The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major
-
www.ndtv.com
-
Caught On Camera: For Bribes, Doctors Will Prescribe You Anything
- Tuesday August 12, 2014
- India News | Sonal Mehrotra
Why do doctors prescribe a branded drug when its generic variant is easily available at a fraction of the price? The Medical Council of India - which is responsible for monitoring doctors and medical practices - says doctors, hospitals and medical colleges should prescribe generic medicines as far as possible.
-
www.ndtv.com
-
India says its drugs safe despite Ranbaxy generics fraud
- Monday June 3, 2013
- India News | Agence France-Presse
India, known as the "pharmacy to the world", today defended its lucrative generic drug industry as safe and strongly regulated after the nation's biggest drug firm pleaded guilty to US charges of making adulterated medicines.
-
www.ndtv.com
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
- Saturday March 21, 2026
- Feature | Edited by Nikhil Pandey
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
www.ndtv.com
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
- Saturday March 21, 2026
- Health | Indo-Asian News Service
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
www.ndtv.com
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
- Friday September 26, 2025
- World News | Edited by Sanstuti Nath
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
www.ndtv.com
-
Zydus Cadila's US Firm Gets US Approval To Market Roflumilast Tablets
- Monday February 14, 2022
- World News | Press Trust of India
Cadlia Healthcare Ltd on Monday said group firm Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market its generic version of Roflumilast tablets in the strength of 500 mcg indicated to reduce the risk of
-
www.ndtv.com
-
High Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of Novartis
- Tuesday November 2, 2021
- India News | Press Trust of India
The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major
-
www.ndtv.com
-
Caught On Camera: For Bribes, Doctors Will Prescribe You Anything
- Tuesday August 12, 2014
- India News | Sonal Mehrotra
Why do doctors prescribe a branded drug when its generic variant is easily available at a fraction of the price? The Medical Council of India - which is responsible for monitoring doctors and medical practices - says doctors, hospitals and medical colleges should prescribe generic medicines as far as possible.
-
www.ndtv.com
-
India says its drugs safe despite Ranbaxy generics fraud
- Monday June 3, 2013
- India News | Agence France-Presse
India, known as the "pharmacy to the world", today defended its lucrative generic drug industry as safe and strongly regulated after the nation's biggest drug firm pleaded guilty to US charges of making adulterated medicines.
-
www.ndtv.com